Rep. Walden Statement on President Trump's Rapid Approval of Major Disaster Declaration
Today, Representative
"On Monday, I spoke with
Yesterday, Walden also joined the Oregon Delegation in sending a letter to
Individuals in
* Apply online at www.disasterassistance.gov
* Call the registration phone number at 1-800-621-3362 (TTY: 800-462-7585).
* For more information on individual assistance, click here https://walden.house.gov/sites/walden.house.gov/files/Fact%20Sheet%20-%20Individual%20Assistance.pdf.
* For more information on public assistance, click here https://walden.house.gov/sites/walden.house.gov/files/Fact%20Sheet%20-%20Public%20Assistance%20Updated%20Oct%202019.pdf.
For more information on



Chairman Scott Subpoenas NLRB Chairman for Documents Regarding Potential Conflicts of Interest
Newsom, Fire-Affected Communities, Conservation Groups Endorse Feinstein Wildfire Bill
Advisor News
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
- Alternative investments in 401(k)s: What advisors must know
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
- Americans unprepared for increased longevity
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
- Lack of digital tools drives wedge between insurers, advisors
- LIMRA: Annuity sales notch 10th consecutive $100B+ quarter
- AIG to sell remaining shares in Corebridge Financial
More Annuity NewsHealth/Employee Benefits News
- Studies from Denise Wolff et al Have Provided New Data on Atopic Dermatitis (AMCP Market Insights: Beyond skin deep on the role of managed care in moderate to severe atopic dermatitis): Skin Diseases and Conditions – Atopic Dermatitis
- New Clinical Trials and Studies Findings from RAND Corporation Described (Benefit design and consumer information: results from a randomized trial): Clinical Research – Clinical Trials and Studies
- School, BOCES healthcare costs up 22%, here’s why
- Healthcare cuts threaten Sullivan's reelection chances in Alaska
- Health insurance marketplace feels growing tremors from GOP cuts
More Health/Employee Benefits NewsLife Insurance News
- Best’s Market Segment Report: AM Best Revises Outlook on Italy’s Life Insurance Segment to Stable From Negative
- Globe Life Inc. (NYSE: GL) Making Surprising Moves in Monday Session
- Dan Scholz to receive NAIFA’s Terry Headley Lifetime Defender Award
- Best’s Special Report: US Property/Casualty and Health Insurers Exceed Cost of Capital; Life Insurers Narrowly Miss
- Aspida Life and WealthVest Offer a Powerful New Guaranteed Income Product with the WealthLock® Income Builder
More Life Insurance News